Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03207867
Title A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUT

Facility Status City State Zip Country Details
University of California, Los Angeles Santa Monica California 90904 United States Details
H Lee Moffitt Cancer Center and Research Institute Inc Tampa Florida 33612 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21205 United States Details
MD Anderson Cancer Center/University of Texas Houston Texas 77030 United States Details
The University of Wisconsin Madison Wisconsin 53792 United States Details
Novartis Investigative Site Caba Buenos Aires C1426ANZ Argentina Details
Novartis Investigative Site Blacktown New South Wales 2148 Australia Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Liege 4000 Belgium Details
Novartis Investigative Site Brno Czech Republic 656 53 Czechia Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Koeln 50937 Germany Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Koto ku Tokyo 135 8550 Japan Details
Novartis Investigative Site Rotterdam 3075 EA Netherlands Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site St. Gallen 9007 Switzerland Details
Novartis Investigative Site Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field